BOSTON ( TheStreet) -- David Einhorn, manager of long-short hedge fund Greenlight Capital, held a concentrated portfolio of 38 stocks at the end of the first quarter. Greenlight has returned upwards of 22% a year since its 1996 inception, underscoring Einhorn's investment acumen. His portfolio underwent a dramatic change during the last quarter.
|David Einhorn (Greenlight Capital)|
He grew even more pessimistic about seven stocks, holdings from the fourth-quarter, which the fund completely sold out of: Everest Re Group (RE), Health Management (HMA), Health Net (HNT), Potash (POT), Verigy (VRGY), Flagstar Bancorp (FBC) and Capitol Federal (CFFND).
In contrast, Einhorn grew particularly bullish on seven stocks during the quarter, building new positions in: AmDocs (DOX - Get Report), Seagate Technology (SKH - Get Report), HCA Holdings (HCA - Get Report) and CVS Caremark (CVS - Get Report).Here is a closer look at three more of Einhorn's new positions. These three stocks may be worth consideration for individual investors.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts